[go: up one dir, main page]

MX2016008583A - Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos. - Google Patents

Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos.

Info

Publication number
MX2016008583A
MX2016008583A MX2016008583A MX2016008583A MX2016008583A MX 2016008583 A MX2016008583 A MX 2016008583A MX 2016008583 A MX2016008583 A MX 2016008583A MX 2016008583 A MX2016008583 A MX 2016008583A MX 2016008583 A MX2016008583 A MX 2016008583A
Authority
MX
Mexico
Prior art keywords
medium chain
immediate release
release film
containing medium
chain glycerides
Prior art date
Application number
MX2016008583A
Other languages
English (en)
Other versions
MX378845B (es
Inventor
Teckoe Jason
J Prusak Bradley
R Gimbel Jffrey
To Daniel
Original Assignee
Bpsi Holdings Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bpsi Holdings Llc filed Critical Bpsi Holdings Llc
Publication of MX2016008583A publication Critical patent/MX2016008583A/es
Publication of MX378845B publication Critical patent/MX378845B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/282—Organic compounds, e.g. fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2813—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2893—Tablet coating processes
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J3/00—Processes of treating or compounding macromolecular substances
    • C08J3/02—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques
    • C08J3/03—Making solutions, dispersions, lattices or gels by other methods than by solution, emulsion or suspension polymerisation techniques in aqueous media

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Application Of Or Painting With Fluid Materials (AREA)
  • Paints Or Removers (AREA)

Abstract

La presente invención se refiere a composiciones de revestimiento de película de liberación inmediata para su uso en formas farmacéuticas orales tales como comprimidos y otros sustratos ingeribles por vía oral que contienen glicéridos de cadena media como antiadherentes. Las composiciones de revestimiento de película se pueden aplicar directamente a un sustrato o después de que el sustrato se haya revestido con una subcapa. En aspectos preferidos, el polímero es alcohol polivinílico y los glicéridos de cadena media son mezclas de mono- y diésteres caprílicos (cadena de 8 carbonos) y cápricos (cadena de 10 carbonos) de glicerina. También se desvelan suspensiones acuosas que comprenden las composiciones de revestimiento de película de la invención, procedimientos de aplicación de los revestimientos a los sustratos y los propios sustratos revestidos.
MX2016008583A 2014-01-21 2015-01-14 Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos. MX378845B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201461929735P 2014-01-21 2014-01-21
PCT/US2015/011422 WO2015112400A1 (en) 2014-01-21 2015-01-14 Immediate release film coatings containing medium chain glycerides and substrates coated therewith

Publications (2)

Publication Number Publication Date
MX2016008583A true MX2016008583A (es) 2017-02-02
MX378845B MX378845B (es) 2025-03-10

Family

ID=53543848

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016008583A MX378845B (es) 2014-01-21 2015-01-14 Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos.

Country Status (14)

Country Link
US (2) US9504654B2 (es)
EP (1) EP3096891B1 (es)
JP (1) JP6541687B2 (es)
KR (1) KR102287342B1 (es)
CN (1) CN105916598B (es)
AU (1) AU2015209674B2 (es)
BR (1) BR112016016623B1 (es)
CA (1) CA2933202C (es)
ES (1) ES2802156T3 (es)
HU (1) HUE049598T2 (es)
MX (1) MX378845B (es)
PL (1) PL3096891T3 (es)
RU (1) RU2686183C2 (es)
WO (1) WO2015112400A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102158339B1 (ko) * 2016-02-05 2020-09-21 삼진제약주식회사 인습성이 개선된 카르베딜롤 속방성 제제
CN109562076B (zh) * 2016-08-04 2022-01-28 Bpsi控股有限责任公司 易于吞咽的涂层和涂覆有该涂层的底物
US20180338922A1 (en) * 2017-05-26 2018-11-29 Esperion Therapeutics, Inc. Fixed dose formulations
TR201721437A2 (tr) * 2017-12-25 2019-07-22 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Fesoterodi̇ni̇n modi̇fi̇ye salim sağlayan formülasyonlari
KR102103530B1 (ko) 2018-06-29 2020-04-22 주식회사 코피텍 필름 코팅용 조성물 및 이를 코팅한 정제
KR102265977B1 (ko) 2018-07-16 2021-06-16 주식회사 코피텍 방습성이 개선된 필름 코팅용 조성물 및 이를 코팅한 정제
JPWO2023063296A1 (es) * 2021-10-11 2023-04-20

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57171428A (en) * 1981-04-13 1982-10-22 Sankyo Co Ltd Preparation of coated solid preparation
DE3220434A1 (de) 1982-05-29 1983-12-01 Robert Bosch Gmbh, 7000 Stuttgart Verfahren zur ueberwachung einer messgroesse
JPS5973529A (ja) 1982-10-12 1984-04-25 Sankyo Co Ltd 被覆固形製剤の製造法
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US6248363B1 (en) * 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
US6448323B1 (en) * 1999-07-09 2002-09-10 Bpsi Holdings, Inc. Film coatings and film coating compositions based on polyvinyl alcohol
KR100425226B1 (ko) * 2001-07-03 2004-03-30 주식회사 팜트리 아세클로페낙을 함유하는 경제적인 경구용 제제의 조성 및제법
CA2471096A1 (en) * 2001-12-19 2003-07-03 Alza Corporation Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules
FR2838647B1 (fr) * 2002-04-23 2006-02-17 Particules enrobees a liberation prolongee, leur procede de preparation et comprimes les contenant
DE10311585A1 (de) * 2003-03-14 2004-09-23 Basf Ag Wirkstoffhaltige Adsorbate
EP1729742A1 (en) 2004-03-31 2006-12-13 BPSI Holdings, Inc. Enteric coatings for orally ingestible substrates
TWI415635B (zh) * 2004-05-28 2013-11-21 必治妥施貴寶公司 加衣錠片調製物及製備彼之方法
US20080096979A1 (en) * 2004-11-08 2008-04-24 Rubicon Research Pvt. Ltd. Aqueous Pharmaceutical Coating
WO2006111980A2 (en) * 2005-04-20 2006-10-26 Ideal Cures Pvt. Ltd. Pva based film coating and film coating compositions
JP2007217390A (ja) * 2006-02-20 2007-08-30 Hitoshi Ichihashi カプリロカプロイルマクロゴール−８グリセリドを含む医薬組成物
US20080181928A1 (en) * 2006-12-22 2008-07-31 Miv Therapeutics, Inc. Coatings for implantable medical devices for liposome delivery
CA2736899C (en) 2008-09-25 2016-08-30 Isp Investments Inc. Smooth, high solids tablet coating composition
TWI438012B (zh) 2008-12-25 2014-05-21 Toray Industries 固態製劑用之塗覆劑及使用其之固態製劑
WO2010112965A1 (en) * 2009-03-30 2010-10-07 Abdi Ibrahim Ilac Sanayi Ve Ticaret Anonim Sirketi Isolation coating of diclofenac tablets
WO2010122583A2 (en) 2009-04-24 2010-10-28 Rubicon Research Private Limited Oral pharmaceutical compositions of acid labile substances
EP2429504A4 (en) * 2009-05-12 2013-05-01 Bpsi Holdings Llc FILM COATINGS WITH DECEPTORS IN FINE PARTICLE SIZES AND SUBSTRATES COATED THEREFOR
CN102421423B (zh) 2009-05-12 2014-11-05 Bpsi控股有限责任公司 增强型防潮即释薄膜包衣系统和覆有该包衣的基体
SG10201500152UA (en) * 2009-12-22 2015-03-30 Abbvie Inc Abt-263 capsule
EP2544546A4 (en) * 2010-03-08 2014-10-15 Sensient Colors Inc FOOD-SPIRITUAL DRYING COATING COMPOSITION AND METHOD FOR THE PRODUCTION AND USE THEREOF
WO2012120364A2 (en) * 2011-03-09 2012-09-13 Ideal Cures Pvt. Ltd. Novel immediate release film coating compositions
US20150320679A1 (en) * 2012-12-12 2015-11-12 Leo Laboratories Limited Gel compositions
WO2014096983A1 (en) * 2012-12-21 2014-06-26 Wockhardt Limited Stable pharmaceutical compositions of saxagliptin or salts thereof
GB201319792D0 (en) * 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations

Also Published As

Publication number Publication date
AU2015209674A1 (en) 2016-06-23
EP3096891B1 (en) 2020-04-08
HUE049598T2 (hu) 2020-09-28
AU2015209674B2 (en) 2018-11-08
ES2802156T3 (es) 2021-01-15
RU2686183C2 (ru) 2019-04-24
WO2015112400A1 (en) 2015-07-30
CN105916598B (zh) 2020-07-17
PL3096891T3 (pl) 2020-08-24
CN105916598A (zh) 2016-08-31
RU2016133221A (ru) 2018-03-02
JP2017509691A (ja) 2017-04-06
JP6541687B2 (ja) 2019-07-10
CA2933202A1 (en) 2015-07-30
BR112016016623A2 (es) 2017-08-08
US20150202160A1 (en) 2015-07-23
EP3096891A1 (en) 2016-11-30
US9504654B2 (en) 2016-11-29
KR20160111375A (ko) 2016-09-26
MX378845B (es) 2025-03-10
RU2016133221A3 (es) 2018-07-17
US9789067B2 (en) 2017-10-17
US20170035697A1 (en) 2017-02-09
BR112016016623B1 (pt) 2022-02-01
EP3096891A4 (en) 2017-10-04
KR102287342B1 (ko) 2021-08-06
CA2933202C (en) 2022-05-31

Similar Documents

Publication Publication Date Title
MX2016008583A (es) Revestimientos de pelicula de liberacion inmediata que contienen gliceridos de cadena media y sustratos revestidos con los mismos.
CL2016002996A1 (es) Método para fabricar un material con superficie modificada que comprende: proporcionar un substrato, que comprende un compuesto alcalino salificable o alcalinotérreo; y aplicar una composición de tratamiento líquida que comprende un ácido; material con superficie modificada; y uso del material
CL2013003019A1 (es) Compuestos derivados de benzotiazol; composicion farmaceutica que los comprende; y su uso en el tratamiento del vih.
CL2016000882A1 (es) Composiciones de arni contra el componente c5 del complemento y métodos para su uso (divisional de sol. n°2710-15).
MX2019013171A (es) Formulaciones muco-adhesivas de liberacion controlada de levodopa y/o esteres de levodopa y sus usos.
CL2014002795A1 (es) Una formulacion de farmaco de liberacion retardada oral para suministrar un farmaco al colon que comprende un nucleo y un recubrimiento para el nucleo, el nucleo comprende un farmaco y el recubrimiento comprende una capa exterior con una mezcla de un primer y segundo material polimerico y una capa interior con un tercer material polimerico; y su metodo de preparacion.
CL2015002304A1 (es) Formas del metil {4,6-diamino-2- [1- (2-fluorobencil)-1h-pirazolo [3,4-b] piridino-3-il] pirimidino-5-il} metil carbamato
CL2017000240A1 (es) Compuestos activos hacia bromodominios
MX2014013347A (es) Composiciones adhesivas que contienen particulas de carbono grafenicas.
CL2014000759A1 (es) Composicion para uso en el crecimiento del cerebro y/o desarrollo cognitivo y/o desarrollo psicomotor que comprende al menos un ácido graso poliinsaturado de cadena larga (lc-pufa), al menos un probiótico y una mezcla de oligosacáridos; uso de la composición.
BR112015030458A2 (pt) método de formação de um artigo
UY32539A (es) Artículo cementicio y método para prepararlo
CL2012003415A1 (es) Compuestos derivados de 2-oxo-piperidina y 1,1-dioxido-tiazina, inhibidores de mdm2; composicion farmaceutica que los comprende; y su uso para el tratamiento del cancer .
CL2015001852A1 (es) Películas de ésteres de poli alfa-1, 3-glucano y metodo para su preparación
MX390737B (es) Estructura de sustrato y metodo para su preparacion.
CL2016002560A1 (es) Forma de dosificación farmacéutica sólida oral que comprende siponimod, un agente protector de la humedad y opcionalmente un excipiente farmacéutico; procedimiento de preparación.
CR20160192A (es) Formulación de farmaco de liberación retardada
CU20120002A7 (es) DERIVADOS DE 1-(5,6-DIHIDROIMIDAZO(1,2-a)PIRAZIN-7(8H)-IL )ETANONA
EP3037870A3 (en) Protecting film and display module including the same and method of manufacturing display module including the same
UY35298A (es) Formulación en dispersión sólida de un compuesto antiviral
CL2017001716A1 (es) Técnicas de recubrimiento de barrera contra gas y artículos producidos mediante las mismas.
AR070850A1 (es) Dispositivo para mejorar un metodo de voladura
BR112015017427A2 (pt) artigo compreendendo um substrato polimérico e uma camada de polímero de silicone
GT201500292A (es) Formas cristalinas de inhibidores de tirosina cinasa y sus sales
WO2012035046A3 (en) Polysaccharide coating with gel particles